These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 38776015)
1. Transcriptomic Analysis of Lipid Metabolism Genes in Alzheimer's Disease: Highlighting Pathological Outcomes and Compartmentalized Immune Status. Sun Y; Jiang M; Long X; Miao Y; Du H; Zhang T; Ma X; Zhang Y; Meng H J Mol Neurosci; 2024 May; 74(2):55. PubMed ID: 38776015 [TBL] [Abstract][Full Text] [Related]
2. Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer's disease. Xu J; Bankov G; Kim M; Wretlind A; Lord J; Green R; Hodges A; Hye A; Aarsland D; Velayudhan L; Dobson RJB; Proitsi P; Legido-Quigley C; Transl Neurodegener; 2020 Sep; 9(1):36. PubMed ID: 32951606 [TBL] [Abstract][Full Text] [Related]
3. Integrated transcriptomics reveals the brain and blood biomarkers in Alzheimer's disease. Yu H; Wang F; Wu JJ; Gong J; Bi S; Mao Y; Jia D; Chai GS CNS Neurosci Ther; 2023 Dec; 29(12):3943-3951. PubMed ID: 37334737 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of oxidative stress and immune-related hub genes in Alzheimer's disease through bioinformatics analysis. Li S; Xiao J; Huang C; Sun J Sci Rep; 2023 Jan; 13(1):657. PubMed ID: 36635346 [TBL] [Abstract][Full Text] [Related]
5. Linking Disulfide Levels and NAD+ Metabolism with Alzheimer's Disease for Diagnostic Modeling and Target Drug Analysis. Wang Y; Su L; Zhang Y; Wei H J Integr Neurosci; 2024 Apr; 23(4):85. PubMed ID: 38682214 [TBL] [Abstract][Full Text] [Related]
6. Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification. Zhong H; Zhou X; Uhm H; Jiang Y; Cao H; Chen Y; Mak TTW; Lo RMN; Wong BWY; Cheng EYL; Mok KY; Chan ALT; Kwok TCY; Mok VCT; Ip FCF; Hardy J; Fu AKY; Ip NY Alzheimers Dement; 2024 Apr; 20(4):2469-2484. PubMed ID: 38323937 [TBL] [Abstract][Full Text] [Related]
7. Identification of key lipid metabolism-related genes in Alzheimer's disease. Zeng Y; Cao S; Li N; Tang J; Lin G Lipids Health Dis; 2023 Sep; 22(1):155. PubMed ID: 37736681 [TBL] [Abstract][Full Text] [Related]
8. [Identification of potential hub genes of Alzheimer's disease by weighted gene co-expression network analysis]. Xue J; Liu J; Geng M; Yue J; He H; Fan J Nan Fang Yi Ke Da Xue Xue Bao; 2021 Dec; 41(12):1752-1762. PubMed ID: 35012905 [TBL] [Abstract][Full Text] [Related]
9. Identification of genes related to glucose metabolism and analysis of the immune characteristics in Alzheimer's disease. Wang Y; Shen Z; Wu H; Yu Z; Wu X; Zhou L; Guo F Brain Res; 2023 Nov; 1819():148545. PubMed ID: 37619853 [TBL] [Abstract][Full Text] [Related]
10. Systematic Analysis of Biological Processes Reveals Gene Co-expression Modules Driving Pathway Dysregulation in Alzheimer's Disease. Adeoye T; Shah SI; Ullah G bioRxiv; 2024 Mar; ():. PubMed ID: 38559218 [TBL] [Abstract][Full Text] [Related]
11. Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease. Levine AJ; Miller JA; Shapshak P; Gelman B; Singer EJ; Hinkin CH; Commins D; Morgello S; Grant I; Horvath S BMC Med Genomics; 2013 Feb; 6():4. PubMed ID: 23406646 [TBL] [Abstract][Full Text] [Related]
12. Integrating peripheral blood and brain transcriptomics to identify immunological features associated with Alzheimer's disease in mild cognitive impairment patients. Qian XH; Liu XL; Chen SD; Tang HD Front Immunol; 2022; 13():986346. PubMed ID: 36159817 [TBL] [Abstract][Full Text] [Related]
13. Condition-specific gene co-expression network mining identifies key pathways and regulators in the brain tissue of Alzheimer's disease patients. Xiang S; Huang Z; Wang T; Han Z; Yu CY; Ni D; Huang K; Zhang J BMC Med Genomics; 2018 Dec; 11(Suppl 6):115. PubMed ID: 30598117 [TBL] [Abstract][Full Text] [Related]
14. Genetic perturbations of disease risk genes in mice capture transcriptomic signatures of late-onset Alzheimer's disease. Pandey RS; Graham L; Uyar A; Preuss C; Howell GR; Carter GW Mol Neurodegener; 2019 Dec; 14(1):50. PubMed ID: 31878951 [TBL] [Abstract][Full Text] [Related]
15. Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise. Yin F FEBS J; 2023 Mar; 290(6):1420-1453. PubMed ID: 34997690 [TBL] [Abstract][Full Text] [Related]
16. Human microRNA-4433 (hsa-miR-4443) Targets 18 Genes to be a Risk Factor of Neurodegenerative Diseases. Ge X; Yao T; Zhang C; Wang Q; Wang X; Xu LC Curr Alzheimer Res; 2022; 19(7):511-522. PubMed ID: 35929619 [TBL] [Abstract][Full Text] [Related]
17. Identification of oxidative stress-related genes differentially expressed in Alzheimer's disease and construction of a hub gene-based diagnostic model. Zhang Y; Kiryu H Sci Rep; 2023 Apr; 13(1):6817. PubMed ID: 37100862 [TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis of diagnostic biomarkers for Alzheimer's disease in peripheral blood based on sex differences and support vector machine algorithm. Ji W; An K; Wang C; Wang S Hereditas; 2022 Oct; 159(1):38. PubMed ID: 36195955 [TBL] [Abstract][Full Text] [Related]
19. Identification of therapeutic targets for Alzheimer's disease via differentially expressed gene and weighted gene co-expression network analyses. Jia Y; Nie K; Li J; Liang X; Zhang X Mol Med Rep; 2016 Nov; 14(5):4844-4848. PubMed ID: 27748870 [TBL] [Abstract][Full Text] [Related]
20. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease. Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]